Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis.

A group of 54 patients with rheumatoid arthritis (31 fast, 23 slow acetylators) treated with sulphasalazine 3 g/day were studied retrospectively. At 24 weeks no difference in the efficacy of the drug could be shown between fast and slow acetylators. In a second prospective study 40 fast acetylators...

Celý popis

Podrobná bibliografie

Vydáno v:	Ann Rheum Dis
Hlavní autoři:	Pullar, T, Hunter, J A, Capell, H A
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMJ Publishing Group 1985
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1001793/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2867746/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.44.12.831
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!